Senior Director of Investor Relations/Public Relations
Posted on: January 15, 2022
Title : Senior Director of Investor Relations/Public Relations
Location : Princeton, NJ
Reporting to : Chief Financial Officer
F2G is a clinical-stage biopharmaceutical company focused on the
discovery and development of novel therapies to treat
life-threatening invasive fungal infections. F2G has discovered and
developed a completely new class of antifungal agents called the
orotomides. The orotomides have a distinct mechanism of action,
selectively targeting fungal dihydroorotate dehydrogenase (DHODH),
a key enzyme in the de novo pyrimidine biosynthesis pathway. This
differentiates the orotomides from the currently marketed
antifungal agents. Olorofim (formerly F901318) is F2G's leading
candidate from this class and has fungicidal activity against a
broad range of mold infections, including a variety of rare and
resistant molds that cause life-threatening infections for which
current therapies have limitations or are ineffective. Olorofim is
in a Phase 2b open-label study focusing on rare and resistant
invasive fungal infections including invasive aspergillosis
(including azole-resistant strains), coccidioidomycosis and
scedosporiosis (including lomentosporiosis). Olorofim has received
orphan drug status from the European Medicines Agency and orphan
drug status, Qualified Infectious Disease Product (QIDP)
designation and Breakthrough Therapy designation from FDA. F2G is
headquartered in the UK with subsidiaries in the US and
F2G's vision is to bring to market safe, convenient, and effective
novel antifungal agents to challenge a global unmet need for
therapies that are active against resistant infections and also
against pathogens which have historically been difficult to treat.
F2G's leading agent, Olorofim, is the first novel anti-fungal
treatment developed in the past 20 years and is the only antifungal
medication ever to be awarded a Breakthrough Therapy Designation
for multiple designations by the FDA. F2G believes that Olorofim,
and subsequent agents, will address some of the many challenges
which face the treating physician and the patient with invasive
F2G opened its US headquarters in mid-2021 and is hiring key
functions in preparation for launching Olorofim. One of the first
roles to be filled is the Senior Director of Investor
Relations/Public Relations (IR/PR). This individual will serve as
the primary strategist on product launch, commercialization, and
investor and public engagement of the F2G brand while ensuring SEC
communications and other compliance requirements are fulfilled.
Devise and execute an effective investor relations engagement
Develop, implement, and oversee coordinated communications to F2G
Investors and stakeholders.
Educate investors and stakeholders about the company, potential
impact, and current and future business plans.
Coordinate and host investor engagement initiatives including
one-on-one meetings, investor days, roadshows, and other
Work with the current CFO and other members of the finance team to
analyze financial data and market projections to make informed
decisions regarding corporate brand strategy.
Work with the CFO to devise and execute a dynamic marketing
communications/brand awareness strategy in support of product
launch and commercialization.
Manage creation and upkeep of all business communications
materials, including slide decks, quarterly business reports,
internal business communications, and SEC reporting.
Manage all external marketing communications to include both
physical materials and digital platforms (i.e. the company website
and social media), campaigns, company writeups, presentations,
conference attendance, and communications to partner
Ensure that all business communications are compliant with SEC
regulations and Regulation Fair Disclosure.
Stay up-to-date with key market trends in the industry and make
adjustments to brand positioning and other marketing efforts to
Ensure that internal and external messaging is aligned.
Develop and maintain key relationships with external vendors.
What You Bring to The Table:
Bachelor's degree required; Master's in relevant subject matter
10-15 years of relevant experience in communications strategy and
execution in support of marketing or investor relations at a
biopharmaceutical or life sciences organization.
A thorough knowledge of SEC reporting and Regulation FD
Knowledge of financial reporting and modeling principles.
Exceptional communication skills and the ability to present complex
information to multiple audiences in a comprehensive manner.
This Job Is Right for You If:
You are a self-starter.
You thrive in a fast-paced startup environment with tight
You can utilize data analysis to inform strategic
Have excellent time and project management skills.
Are passionate about educating diverse audiences about treatments
for rare diseases.
To apply, please visit our Careers page at www.f2g.com and submit
your resume to firstname.lastname@example.org.
Engage with us on our LinkedIn page as well at
Keywords: F2G, Trenton , Senior Director of Investor Relations/Public Relations, Executive , Princeton, New Jersey
Didn't find what you're looking for? Search again!